Harvard Business Review

MAY 8, 2013

Over the past 20 years, no group has endured greater pain and humiliation within organizations than mid-level managers (MLMs — managers from two levels below the CEO down to the line managers). Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

OCTOBER 23, 2014

Energy, agriculture, insurance, retail, human resources — no industry is unaffected. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Or lenders’ enhanced abilities to gauge credit risk. They’re also sharing risk. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

AUGUST 14, 2018

“Death by a Thousand Cuts” Based on a comprehensive five-year study, my new research paper, published in the Academy of Management Discoveries this year, systematically identifies the reasons behind the failures of major Western digital firms in China. poor management of relations with Chinese regulators and the government.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

JANUARY 24, 2012

Nine years ago, when I launched The Energy Project during an economic boom, it was nearly impossible to find senior leaders open to the idea that demand was exceeding people's capacity, and that it was critical to the bottom line to teach employees new ways to manage their energy more skillfully.

Meyer 15

Meyer Goleman Emotional Intelligence Pharmaceuticals 15

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products. but also the risks.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Let’s say you’re in the energy sector. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

APRIL 22, 2013

Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." Socialize your underused assets.

Mission Statement 9

Mission Statement Class Learning-by-Doing Pharmaceuticals 9

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. They are empowered by – and in frequent communication with – senior management. in less than five years. in less than five years. Shared Spaces.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

SEPTEMBER 15, 2014

Consider Ashoka , which provides start-up funding and support for social innovators worldwide. Instead of passive subscribers, it created “communities of friends” who generated new story ideas and collaborated with Fast Company staff to develop themes of the “new management revolution.”. Informal leadership Managing people'

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

APRIL 16, 2012

energy or telecom) or research-intensive industries (e.g., high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g.,

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

FEBRUARY 10, 2014

Back in 2006, my colleague Huggy Rao and I launched an executive education program at Stanford called “Customer-focused Innovation.” The most effective campaigns stir up “hot” emotions in people (pride and anger are especially effective) and then channel that energy and passion into “cool” (clear and step-wise) actions.

Case Study 10

Case Study Pharmaceuticals Airlines Hotels 10

Harvard Business Review

MAY 16, 2011

But most true collaborations cannot be controlled with fixed terms that are defined in advance — they must be managed through relational contracts that allow you to respond flexibly to new information. Their challenge then is to learn how to manage these partnerships differently than the vendor relationships they had before.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

MARCH 9, 2015

Big data and analytics can make organizations more efficient and agile by empowering middle-level and far-flung managers to make decisions and seize business opportunities that previously required scarce data and executive approval. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

MAY 17, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). Management Flaws at I.R.S. OK, you know I have to say it: Of course this scandal boils down to a massive management problem. Just Add Training! Cited in Tea Party Scrutiny The New York Times.

Pharmaceuticals 8

Pharmaceuticals Course Middle Management Training 8

Harvard Business Review

FEBRUARY 20, 2014

This may all change as China innovates and grows. But we also make super-sophisticated products like jet engines, airplanes, satellites, radar, advanced medical devices, pharmaceuticals, all kinds of chemicals, the world’s most sophisticated robots, military goods, and the world’s most advanced computer chips and computers.

Intellectual Capital 8

Intellectual Capital Magazine Chemicals Creativity 8

Harvard Business Review

OCTOBER 27, 2014

A mid-level manager in this 5,000-employee hospital, she is leading a 70-member group on patient flow as part of a larger organizational effort. Her ability to lead and inspire — to become a change leader from her position as a mid-level manager — is helping her team produce results. I found a few defining characteristics: 1.

Middle Management 13

Middle Management Six Sigma Taylorism Taylor 13

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 13

Innovation Supply Chain Policies Offshoring 13

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. ” Yet that poses a problem for managers. In the pharmaceutical industry, the monitoring process can be incredibly elaborate.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Corporate directors identified talent management as their single greatest strategic challenge. We know that organizations commit enormous resources and effort to talent management, so why aren''t they doing a better job? Not rising costs.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

NOVEMBER 20, 2015

But entrepreneurial know-how and energy can work very effectively in the context of plugging-in as a supplier, as Steve Cronce and thousands of others are learning. Manage culture by setting expectations appropriately. Manage the arduously long sales cycle. Taking this path isn’t a cake walk, however.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Great Leadership By Dan

FEBRUARY 7, 2014

After motivational ability, the senior executive traits most valued by organizations were: strong ability to manage change (51 percent); ability to identify and develop talent (46 percent); innovative thinking (30 percent); and consistent high performance (26 percent). years), while the pharmaceutical (5.7

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

NOVEMBER 3, 2017

The team tasked with overseeing the effort designed an aggressive implementation plan that tied targets to manager compensation. When everyone in the organization feels empowered to make decisions that can influence change, it creates a palpable energy: People tend to work harder, offer more ideas, and become far more invested in the process.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JUNE 20, 2017

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.

Supply Chain 9

Supply Chain Depreciation Uncertainty Marketing 9

Harvard Business Review

MAY 12, 2011

Here's what I see when I look not just at the surface, but deep inside the heart of the economy today: Instead of an "energy industry," I see a resource addiction that saps money and preserves self-destructive expectations. Gary Hamel , whose Future of Management is about creating the capacity to live better.

GDP 21

GDP Hamel Industry Construction 21